Intelligence Platform

Patents

Browse 912 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 6326466

Double-stranded RNA dependent protein kinase derived peptides to promote proliferation of

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 04 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6326198

Methods and compositions for the ex vivo replication of stem cells, for the optimization o

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 04 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6319496

Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6316206

Method for screening comprising cells expressing the CNTF receptor

REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6300104

Secretory immunoglobulin produced by single cells and methods for making and using same

The Regents of the University of California · Granted Tue Oct 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6297219

Site-specific instillation of cells or site-specific transformation of cells and kits ther

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 02 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6287562

Methods of inhibiting the growth of cells bearing LewisY antigens using B1, B3, or B5 targ

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6287792

Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells u

The Regents of the University of California · Granted Tue Sep 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6277368

Cancer immunotherapy using autologous tumor cells combined with cells expressing a membran

The Regents of the University of California · Granted Tue Aug 21 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6262244

DNA and amino acid sequence specific for natural killer cells

Regents of the University of Minnesota · Granted Tue Jul 17 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6261841

Compositions, kits, and methods for modulating survival and differentiation of multi-poten

The Board of Trustees of Northwestern University · Granted Tue Jul 17 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6248351

Human PEA3 is a tumor suppressor for cancer cells

The Board of Regents of the University of Texas System · Granted Tue Jun 19 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6248791

Stimulating the differentiation of preadipocytic cells and therapies based thereon

Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma · Granted Tue Jun 19 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6245563

Enhanced activation of natural killer cells using an NK cell activator and hydrogen peroxi

Maxim Pharmaceuticals, Inc. · Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6232086

Method for detecting cancer cells

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 15 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6231852

Method for reducing BCL-2 expressing cells resistance to death

The Regents of the University of California · Granted Tue May 15 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6214388

Immunoliposomes that optimize internalization into target cells

The Regents of the University of California · Granted Tue Apr 10 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6214571

Method for inhibiting adenylosuccinate synthetase activity in malignant methylthioadenosin

The Regents of the University of California · Granted Tue Apr 10 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6210917

Method for suppressing multiple drug resistance in cancer cells

The Regents of the University of California · Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6207412

Identification of a G protein-coupled receptor transcriptionally regulated by protein tyro

The Regents of the University of California · Granted Tue Mar 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6207147

Cancer immunotherapy using tumor cells combined with mixed lymphocytes

The Regents of the University of California · Granted Tue Mar 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6203787

Treating tumors using implants comprising combinations of allogeneic cells

The Regents of the University of California · Granted Tue Mar 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6197586

Chondrocyte-like cells useful for tissue engineering and methods

The Regents of the University of California · Granted Tue Mar 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6197578

Cells expressing both human CD4 and a human fusion accessory factor associated with HIV in

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)